Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 406

1.

HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.

Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, Semini I, Tawil O, Akala FA, Wilson D, Abu-Raddad LJ.

PLoS Med. 2014 Jun 17;11(6):e1001663. doi: 10.1371/journal.pmed.1001663. eCollection 2014 Jun. Review.

2.

Are HIV epidemics among men who have sex with men emerging in the Middle East and North Africa?: a systematic review and data synthesis.

Mumtaz G, Hilmi N, McFarland W, Kaplan RL, Akala FA, Semini I, Riedner G, Tawil O, Wilson D, Abu-Raddad LJ.

PLoS Med. 2010 Aug;8(8):e1000444. doi: 10.1371/journal.pmed.1000444. Epub 2011 Aug 2. Review.

3.

Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa.

Mumtaz GR, Weiss HA, Vickerman P, Larke N, Abu-Raddad LJ.

AIDS. 2015 Aug 24;29(13):1701-10. doi: 10.1097/QAD.0000000000000761.

4.

HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa.

Abu-Raddad LJ, Schiffer JT, Ashley R, Mumtaz G, Alsallaq RA, Akala FA, Semini I, Riedner G, Wilson D.

Epidemics. 2010 Dec;2(4):173-82. doi: 10.1016/j.epidem.2010.08.003. Epub 2010 Sep 15. Review.

5.

HIV surveillance in MENA: recent developments and results.

Bozicevic I, Riedner G, Calleja JM.

Sex Transm Infect. 2013 Nov;89 Suppl 3:iii11-16. doi: 10.1136/sextrans-2012-050849. Epub 2013 Feb 23.

6.

Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis.

Heijnen M, Mumtaz GR, Abu-Raddad LJ.

J Int AIDS Soc. 2016 May 27;19(1):20873. doi: 10.7448/IAS.19.1.20873. eCollection 2016. Review.

7.

Epidemiology of HIV among female sex workers, their clients, men who have sex with men and people who inject drugs in West and Central Africa.

Papworth E, Ceesay N, An L, Thiam-Niangoin M, Ky-Zerbo O, Holland C, Dramé FM, Grosso A, Diouf D, Baral SD.

J Int AIDS Soc. 2013 Dec 2;16 Suppl 3:18751. doi: 10.7448/IAS.16.4.18751. Review.

8.

HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.

Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD, Cribbin M, Krishna N, Teshale EH, Paz-Bailey G; National HIV Behavioral Surveillance System Study Group.

MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.

9.

Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa.

Chaabna K, Mohamoud YA, Chemaitelly H, Mumtaz GR, Abu-Raddad LJ.

Syst Rev. 2014 Dec 16;3:146. doi: 10.1186/2046-4053-3-146. Review.

10.

The emerging face of the HIV epidemic in the Middle East and North Africa.

Mumtaz GR, Riedner G, Abu-Raddad LJ.

Curr Opin HIV AIDS. 2014 Mar;9(2):183-91. doi: 10.1097/COH.0000000000000038. Review.

11.

Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Mohamoud YA, Miller FD, Abu-Raddad LJ.

World J Gastroenterol. 2014 Sep 28;20(36):12734-52. doi: 10.3748/wjg.v20.i36.12734. Review.

12.

New evidence on the HIV epidemic in Libya: why countries must implement prevention programs among people who inject drugs.

Mirzoyan L, Berendes S, Jeffery C, Thomson J, Ben Othman H, Danon L, Turki AA, Saffialden R, Valadez JJ.

J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):577-83. doi: 10.1097/QAI.0b013e318284714a.

PMID:
23337363
13.

An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India.

Goswami P, Medhi GK, Armstrong G, Setia MS, Mathew S, Thongamba G, Ramakrishnan L, George B, Singh RK, Paranjape RS, Mahanta J.

Int J Drug Policy. 2014 Sep;25(5):853-64. doi: 10.1016/j.drugpo.2014.04.016. Epub 2014 May 28.

14.

High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.

Des Jarlais DC, Feelemyer JP, Modi SN, Abdul-Quader A, Hagan H.

BMC Public Health. 2013 Jan 19;13:53. doi: 10.1186/1471-2458-13-53. Review.

15.
16.

Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West.

Uusküla A, Raag M, Folch C, Prasad L, Karnite A, van Veen MG, Eritsyan K, Rosinska M, Des Jarlais DC, Wiessing L.

AIDS. 2014 Jul 17;28(11):1657-64. doi: 10.1097/QAD.0000000000000299.

PMID:
25232900
17.

Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.

Petersen Z, Myers B, van Hout MC, Plüddemann A, Parry C.

Harm Reduct J. 2013 Aug 19;10:13. doi: 10.1186/1477-7517-10-13.

18.

Drug use and sexual behavior: the multiple HIV vulnerabilities of men and women who inject drugs in Kumasi, Ghana.

Messersmith LJ, Adjei R, Beard J, Agyarko-Poku T, Wondergem P, Falconer A, Sabin L, Adu-Sarkodie Y.

J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S124-30. doi: 10.1097/QAI.0000000000000445.

PMID:
25723976
19.

Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data.

Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Mathers BM, Degenhardt L, Hagan H.

PLoS One. 2012;7(3):e31227. doi: 10.1371/journal.pone.0031227. Epub 2012 Mar 1.

20.

HIV prevalence and risk behaviors among people who inject drugs in two serial cross-sectional respondent-driven sampling surveys, Zanzibar 2007 and 2012.

Matiko E, Khatib A, Khalid F, Welty S, Said C, Ali A, Othman A, Haji S, Kibona M, Kim E, Broz D, Dahoma M.

AIDS Behav. 2015 Feb;19 Suppl 1:S36-45. doi: 10.1007/s10461-014-0929-2.

PMID:
25399032
Items per page

Supplemental Content

Write to the Help Desk